Business / Finance

RSS

Centene's AHCCCS receives Bridgeway contract to deliver Arizona Long Term Care System services

Centene Corporation was notified that the Arizona Health Care Cost Containment System has awarded Bridgeway Health Solutions, Centene's Arizona subsidiary, contracts to deliver Arizona Long Term Care System services.

9 May 2011

caprotec bioanalytics closes Series B financing for EUR 5 million

caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.

9 May 2011

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

Flamel Technologies today announced its financial results for the first quarter of 2011.

9 May 2011

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Heptares Therapeutics today announced it has signed an exclusive option agreement with Shire Pharmaceuticals for a novel adenosine A2A antagonist discovered by Heptares and currently in preclinical development.

9 May 2011

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.

9 May 2011

Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio

In today's highly competitive marketplace, bio-pharmaceutical companies often look to expand their product portfolios in the same indication. This "double-dipping" can result in a new brand gaining more profitability at the expense of a more established brand.

9 May 2011

MaxID wins 1000-unit sale of iDL500 multi-modal mobile computer in South Africa

MaxID Pty Ltd, a wholly owned company of MaxID Corp, a leading provider of mobile identity solutions, is pleased to announce that it has won a 1000-unit sale of its iDL500 units in South Africa.

9 May 2011

MedCath sells ownership interest, management agreement in Coastal Carolina Heart to North Carolina hospital

MedCath Corporation announced today it has completed the sale of its ownership interest and management agreement in Coastal Carolina Heart to New Hanover Regional Medical Center.

7 May 2011

Cegedim Relationship Management's co-pay savings card programs presented at PMSA conference

The OPUS Health division of Cegedim Relationship Management conducted a presentation entitled Best Practices in ROI Methodologies in Analyzing the Effectiveness of Patient Co-pay Savings Cards at the 2011 Annual Pharmaceutical Management Science Association Conference in Miami, Florida.

7 May 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.

7 May 2011

Paragon's offerings and solutions to be showcased at EMC World Conference

Paragon Solutions, a business and information technology consulting firm, announced today that it will be showcasing its offerings and solutions at the 2011 EMC World Conference from May 9th to May 12th at the Venetian Hotel and Casino in Las Vegas, Nevada.

7 May 2011

Allied Healthcare reports net income of $60,000 for quarter ending March 31, 2011

With tight budgets continuing to constrain its healthcare markets, Allied Healthcare Products reported a modest profit in the third quarter of fiscal year 2011 and further improvement in its year-over-year performance.

7 May 2011

Halozyme Therapeutics reports net loss of $9.6 million for first quarter 2011

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today reported financial results for the first quarter 2011.

7 May 2011

Centric Health to acquire LifeMark Health

Centric Health Corporation, Canada's leading diversified healthcare company, announced today that it has entered into an agreement to acquire, amongst other things, all of the common units of LifeMark Health Limited Partnership.

7 May 2011

West declares third quarter dividend of $0.17 per share

West Pharmaceutical Services, Inc. today announced that its Board of Directors has approved payment of the third-quarter 2011 cash dividend of $0.17 per share.

7 May 2011

Enzon first quarter adjusted loss from continuing operations decreases to $4.2 million

Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.

7 May 2011

Helix BioMedix total revenue increases 413% to $358,000 for first quarter 2011

Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the company's first quarter ended March 31, 2011.

7 May 2011

Spherix effects 1-for-10 reverse stock split

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation, as amended, to effect a 1-for-10 reverse stock split of its common stock that will become effective at end of business today.

7 May 2011

Sonova reports record consolidated sales of CHF 1.617 billion for 2010/11

Sonova announces preliminary financial results for the 2010/11 year which includes consolidated sales of CHF 1.617 billion, a new record for the company, and an EBITA of CHF 326.6 million, or 20.2% of net sales.

7 May 2011

Rotech Healthcare first quarter adjusted EBITDA increases 13% to $28.3 million

Rotech Healthcare Inc. today announced financial results for the first quarter ended March 31, 2011.

7 May 2011

Business / Finance

Centene's AHCCCS receives Bridgeway contract to deliver Arizona Long Term Care System services

caprotec bioanalytics closes Series B financing for EUR 5 million

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio

MaxID wins 1000-unit sale of iDL500 multi-modal mobile computer in South Africa

MedCath sells ownership interest, management agreement in Coastal Carolina Heart to North Carolina hospital

Cegedim Relationship Management's co-pay savings card programs presented at PMSA conference

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Paragon's offerings and solutions to be showcased at EMC World Conference

Allied Healthcare reports net income of $60,000 for quarter ending March 31, 2011

Halozyme Therapeutics reports net loss of $9.6 million for first quarter 2011

Centric Health to acquire LifeMark Health

West declares third quarter dividend of $0.17 per share

Enzon first quarter adjusted loss from continuing operations decreases to $4.2 million

Helix BioMedix total revenue increases 413% to $358,000 for first quarter 2011

Spherix effects 1-for-10 reverse stock split

Sonova reports record consolidated sales of CHF 1.617 billion for 2010/11

Rotech Healthcare first quarter adjusted EBITDA increases 13% to $28.3 million

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News